Navigation Links
Ultra low-dose estrogen shown safe for post-menopausal women

e women who took estradiol compared to the women who took placebo. The current study was a pre-planned secondary investigation.

Yaffe speculates that the differences in health and cognition outcomes between these two studies and the WHI studies could be related to three factors: dose, type of estrogen, and means of delivery.

The women in the WHI studies received .625 milligrams per day of conjugated estrogen ?a mixture of estrogen from several different sources ?in pill form. In contrast, the women studied by Yaffe and her associates received a daily dose of estradiol ?pure human estrogen ?that was over 44 times smaller and delivered through a skin patch.

"The different between a patch and a pill is significant because medications taken in pill form are processed through the liver before they reach the bloodstream," explains Yaffe. "It's thought that estrogen in pill form might stimulate the liver to produce substances that can lead to clotting or other adverse side effects. With a patch, you bypass the liver and go straight to the blood."

Yaffe notes that since the WHI results were announced in 2004, "the field of estrogen research has been stymied. Hopefully, this study will start to turn the tide."


'"/>

Source:University of California - San Francisco


Page: 1 2

Related biology news :

1. Ultrasounds show mothers drinking shrinks fetal brain
2. Ultrasound may help regrow teeth
3. Ultrathin films deliver DNA as possible gene therapy tool
4. Ultrasound upgrade produces images that work like 3-D movies
5. Harmful chemicals may reprogram gene response to estrogen
6. Compounds in plastic packaging act as environmental estrogens altering breast genes
7. Tamoxifen-like drug suggests new ways to selectively block estrogen
8. Researchers uncover mechanisms of estrogen in promoting cell death in breast cancer
9. High estrogen levels associated with dementia in older men
10. New path from estrogen to survival in breast cancer cells described
11. Changing length of days reverses how estrogen affects aggressiveness in mice
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Ultra low dose estrogen shown safe for post menopausal women

(Date:7/30/2014)... spinal cord injury (SCI), traumatic brain injury (TBI) and ... has been learned over the past 30 years regarding ... regulate axon growth, but this large body of information ... Lemmon and his team from University of Miami in ... but a consensus is emerging that one contributing factor ...
(Date:7/30/2014)... analysis of the roughly 3,000 pieces is still in ... the results will be of major significance. "Amazingly often, ... species in Fushun amber that we found in Baltic ... , The Baltic amber comes from the Baltic Sea ... rich in finds are, e.g., the coastal regions of ...
(Date:7/30/2014)... Washington, DCToday scientists unveiled the first high-resolution map ... the entire country of Per. The new and ... a sea change for future market-based carbon economies. ... extremely high ecological diversity and it provides the ... degradation for conservation, land use, and enforcement purposes. ...
Breaking Biology News(10 mins):Chinese mosquitos on the Baltic Sea 2Peru's carbon quantified: Economic and conservation boon 2Peru's carbon quantified: Economic and conservation boon 3
... Deborah A. Frank, MD, the Director of the Grow ... a Professor of Pediatrics at Boston University School of ... from the National Institutes of Health to study the ... substance exposure (IUSE). The project, entitled Prenatal ...
... , Researchers at Yale School of Medicine have found ... type leads to Type 1 Gaucher disease, a rare ... in cells, resulting in liver/spleen enlargement, osteoporosis, bone pain, ... The new findings could lead to less expensive ...
... This release is available in French . , ... Neuro, McGill University have discovered that our brains have the ... processing specially-coded sounds, without any visual or tactile input. Not ... of the brain and how it perceives the world around ...
Cached Biology News:Cheaper, more effective treatment of type 1 Gaucher disease possible 2See no shape, touch no shape, hear a shape? 2
(Date:7/30/2014)... July 30, 2014  Orexigen Therapeutics, Inc. (Nasdaq: ... Day 180 List of Outstanding Issues (LOI) from the ... Use (CHMP) for the NB32 Marketing Authorization Application (MAA). ... an investigational drug candidate being evaluated for weight loss. ... 120 time point were adequately addressed by the Company ...
(Date:7/30/2014)... 2014 Researchers often use microelectronic devices ... such devices can do much more – perhaps ... researchers have looked to patterned assemblies of proteins ... engineering to characterize – and potentially control – ... envisioned to recreate animal and human physiological functions ...
(Date:7/30/2014)... , July 30, 2014  AtheroNova Inc. (OTCBB: ... and development of compounds to safely regress atherosclerotic ... announces that its partner, CardioNova, has accomplished first ... trial with AtheroNova,s lead compound, AHRO-001.  This Phase ... AHRO-001 Phase 1 safety trial completed in February ...
(Date:7/30/2014)... NCERC at Southern Illinois University ... findings on corn stover pretreatment methods at a ... Washington, D.C. , “Arun’s selection for presentation ... testament to the success of our postdoctoral fellowship ... the foresight and vision of SIUE and the ...
Breaking Biology Technology:Orexigen Receives CHMP Day 180 List of Outstanding Issues 2Orexigen Receives CHMP Day 180 List of Outstanding Issues 3UMD Researchers Bridge Gap between Microelectronics, Biological Systems 2UMD Researchers Bridge Gap between Microelectronics, Biological Systems 3UMD Researchers Bridge Gap between Microelectronics, Biological Systems 4AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 2AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 3AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 4NCERC at SIUE Researcher Takes Stage at Department of Energy Conference 2NCERC at SIUE Researcher Takes Stage at Department of Energy Conference 3
... victory for its client,Applera Corporation, a global leader in ... summary judgment ruling invalidating three key,contested life sciences patents. ... DNA sequencing reagents and instruments infringed,the patents in question. ... Bond Arterton of the,United States District Court for the ...
... a civil settlement with the U.S. Department of ... the federal False Claims Act,relating to Anzemet(R) involving ... The settlement relates to government claims that ... turn increased the cost of,government reimbursements for the ...
... 10 BioStorage Technologies, Inc.,(BST) announced that it ... Company (IPL) to purchase electricity generated by 100 ... voluntary,program. By offsetting the use of fossil-fueled power ... completely carbon-neutral by 2009. BST becomes the ...
Cached Biology Technology:Weil Gotshal Wins Major Victory for Applera; Secures Summary Judgment Invalidating Three Patents 2BioStorage Technologies Becomes Green Powered through the Use of 100% Certified Renewable Energy 2BioStorage Technologies Becomes Green Powered through the Use of 100% Certified Renewable Energy 3BioStorage Technologies Becomes Green Powered through the Use of 100% Certified Renewable Energy 4
...
... Western Blot Strong Antibody Stripping Solution is ... blots that have been developed with chemiluminescence ... is not recommended for stripping colorimetric substrates ... not possible to effectively remove substrates that ...
... Liquid. 100 ml supplied as a ... remove antibodies from membrane-bound proteins without ... stripping chemiluminescent or radioisotopic signals from ... Western blots. Supplied as a 5X ...
... is specifically designed for two-dimensional electrophoresis ... four proteins in this marker have ... pattern across a 2D gel. The ... Mol wt: 17,000-89,000 ...
Biology Products: